Mental health service users' progression from illicit drug use to schizophrenia in New Zealand

4Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Background: Recently, publications have hypothesised that the demonstrated increase in the incidence of schizophrenia in New Zealand is a side effect of the increased strength of available cannabis derivatives over the last 25+ years and the much more recent increase in the population's use of methamphetamine. Aim: To compare the rates of later schizophrenia between age-matched mental health service users with initial diagnoses as alcohol abusers or illicit drug users. Method: From the PRIMHD comprehensive national database, all users of the mental health services over a 5-year period who received an ICD-10 presenting diagnosis of alcohol or substance use/abuse were identified. For each person identified, the database was examined for the following 3 years to determine the numbers later diagnosed with schizophrenia. Results: For the initial alcohol problem people in their twenties, 1.7% were diagnosed as suffering from schizophrenia in the subsequent 3 years. For the initial drug problem people, the rate was 10.9%. Within that drug-using population, the indigenous Maori developed schizophrenia at a higher rate than did the remainder of the population. Conclusion: These findings in New Zealand require further research into their generalisability, context and explanation.

Author supplied keywords

Cite

CITATION STYLE

APA

Mellsop, G., Tapsell, R., & Holmes, P. (2019). Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand. General Psychiatry, 32(5). https://doi.org/10.1136/gpsych-2019-100088

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free